Przedstawiamy wybór publikacji naukowych związanych z immunoterapią IOZK. Możesz użyć filtrów, aby dokonać wyboru według typów nowotworów i metod lub wprowadzić wyszukiwane hasła.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-26 / J. Cancer Res. Clin. Oncol. 2008 Sep;134(9):987-94https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-26 / J. Cancer Res. Clin. Oncol. 2008 Sep;134(9):987-942008-02-26 00:00:002019-02-15 09:19:23Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-13 / Cancer Immunol. Immunother. 2008 Sep;57(9):1421-72008-02-13 00:00:002021-11-15 17:05:45Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-91https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-05 / Br. J. Cancer 2008 Feb;98(4):784-912008-02-05 00:00:002008-02-05 00:00:00Immunisation with ’naïve‘ syngeneic dendritic cells protects mice from tumour challenge
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-01 / Oncologist 2008 Feb;13(2):175-86https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-01 / Oncologist 2008 Feb;13(2):175-862008-02-01 00:00:002008-02-01 00:00:00Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-78https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):67-782008-02-01 00:00:002019-02-15 09:17:40Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-56https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-01 / Int J Hyperthermia 2008 Feb;24(1):41-562008-02-01 00:00:002019-02-15 09:17:41Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-70https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-01 / G Ital Dermatol Venereol 2008 Feb;143(1):59-702008-02-01 00:00:002019-02-15 09:19:20Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-11https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-02-01 / Zhonghua Zhong Liu Za Zhi 2008 Feb;30(2):107-112008-02-01 00:00:002008-02-01 00:00:00[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-40https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-01-28 / World J. Gastroenterol. 2008 Jan;14(4):532-402008-01-28 00:00:002019-02-15 08:38:06An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-01-25 / J Transl Med 2008 Jan;6:6https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-01-25 / J Transl Med 2008 Jan;6:62008-01-25 00:00:002019-02-15 09:19:34A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):1807https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2008-01-23 / Ann. Surg. Oncol. 2008 Jun;15(6):18072008-01-23 00:00:002019-02-15 09:19:29Dendritic cells in patients with melanoma
Dendritic cell based genetic immunization stimulates potent tumor protection dependent on CD8 CTL cells in the absence of autoimmunity
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses
Second International Conference on Cancer Vaccines/Adjuvants/Delivery for the Next Decade (CVADD): Heidelberg, Germany, 10-12 October 2007
Dendritic cell vaccines in melanoma: from promise to proof?
Immunisation with ’naïve‘ syngeneic dendritic cells protects mice from tumour challenge
Neoadjuvant treatment of locally advanced soft tissue sarcoma of the limbs: which treatment to choose?
Dendritic cell-based immunotherapy for malignant glioma
Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
Targeted regulation of a lymphocyte-endothelial-interleukin-6 axis by thermal stress
Dissecting the role of hyperthermia in natural killer cell mediated anti-tumor responses
Immunotherapy as an adjuvant therapy in the management of advanced, surgically resected, melanoma
Immunotherapy opportunities in ovarian cancer
Dendritic cell vaccination induces tumor epitope-specific Th1 immune response in medullary thyroid carcinoma
Immunotherapy in mantle cell lymphoma: anti-CD20-based therapy and beyond
[Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells]
An effective vaccine against colon cancer in mice: use of recombinant adenovirus interleukin-12 transduced dendritic cells
A phase I clinical study of vaccination of melanoma patients with dendritic cells loaded with allogeneic apoptotic/necrotic melanoma cells. Analysis of toxicity and immune response to the vaccine and of IL-10 -1082 promoter genotype as predictor of disease progression
Dendritic cells in patients with melanoma
Efficient monocyte-derived dendritic cell generation in patients with acute myeloid leukemia after chemotherapy treatment: application to active immunotherapy
Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer